Coagulation Modifying Agents Part 1: Antiplatelets and Anticoagulants Flashcards
PARENTERAL • Heparin Type Products a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
a. Heparin, Enoxaparin
PARENTERAL • Non-Heparin Products a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
b. Argatroban, Fondaparinux
ORAL • Vitamin K Antagonists a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
c. Warfarin
ORAL • NOAC/DOACs a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
d. Apixaban, Rivaroxaban, Dabigatran
◦ Can be used in Pregnant Patients
a. Heparin, Enoxaparin
b. Argatroban, Fondaparinux
c. Warfarin
d. Apixaban, Rivaroxaban, Dabigatran
Heparin
USED TO DVT prophylaxis ◦ DVT/PE treatment (therapeutic) a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
Heparin
The Steps for Heparin SQ
•For subcutaneous injections, use a 20- to 22-gauge needle to withdraw medication from the vial.
Then, change the needle to a smaller needle (25- or 26-gauge, ½ to ⅝ inches long).
•Administer deep subcutaneous injections in the abdomen, ensuring a distance of at least 2
inches from the umbilicus
•Do not aspirate
•Apply gentle pressure for 1 to 2 min after the injection.
•Rotate and record injection sites
dddd
◦ Body- ◦ Petechiae, bruising, hematoma a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
a. Heparin, Enoxaparin
OTHER ADVERSE EFFECTS ◦ Osteoporosis – LONG TERM a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
a. Heparin, Enoxaparin
OTHER ADVERSE EFFECTS ◦ Osteoporosis – LONG TERM a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
a. Heparin, Enoxaparin
b. Argatroban, Fondaparinux
•REVERSAL AGENT/ANTIDOTE • Protamine Sulfate a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
a. Heparin, Enoxaparin
•CONTRA-INDICATIONS ◦ AVOID in epidurals + neurosurgery ◦ Hematoma in the spine can cause swelling which can lead to paralysis a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
a. Heparin, Enoxaparin
b. Argatroban, Fondaparinux
• Pork allergy- from intestinal mucosa from pigs, Pork- religious • Recommend consulting professional a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
a. Heparin, Enoxaparin
b. Argatroban, Fondaparinux
Check aPTT for appropriate range, review CBC (H/H,Plts)
a. Heparin, Enoxaparin
b. Argatroban, Fondaparinux
c. Warfarin
d. Apixaban, Rivaroxaban, Dabigatran
a. Heparin, Enoxaparin
b. Argatroban, Fondaparinux
S/s of bleeding, Monitor Hgb/hct/plts
a. Heparin, Enoxaparin
b. Argatroban, Fondaparinux
c. Warfarin
d. Apixaban, Rivaroxaban, Dabigatran
a. Heparin, Enoxaparin
S/s of bleeding, Monitor Hgb/hct/plts
a. Heparin, Enoxaparin
b. Argatroban, Fondaparinux
c. Warfarin
d. Apixaban, Rivaroxaban, Dabigatran
a. Heparin, Enoxaparin
b. Argatroban, Fondaparinux
Weight based dosing, 80 kg patient
◦ 80 mg SC every 12 hours
a. Heparin, Enoxaparin
b. Argatroban, Fondaparinux
c. Warfarin
d. Apixaban, Rivaroxaban, Dabigatran
Enoxaparin
◦ General adult dose is 5,000 units SC every 8 or 12 hours
a. Heparin, Enoxaparin
b. Argatroban, Fondaparinux
c. Warfarin
d. Apixaban, Rivaroxaban, Dabigatran
Heparin
◦ General adult dose is 5,000 units SC every 8 or 12 hours
a. Heparin, Enoxaparin
b. Argatroban, Fondaparinux
c. Warfarin
d. Apixaban, Rivaroxaban, Dabigatran
Heparin
•USED TO TREAT (Continuous IV drip) • patients who have developed HIT • Hx of HIT with active PE/DVT a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
Argatroban
USED TO TREAT • Continuous IV drip- patients who have developed HIT a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
Argatroban
USED TO TREAT (Subcutaneous injection) • patients who have developed HIT • Hx of HIT with active PE/DVT • DVT/PE prophylaxis or treatment a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
Fondaparinux
Wich cause HIT- Heparin induced thrombocytopenia causes
a. Heparin, Enoxaparin
b. Argatroban, Fondaparinux
c. Warfarin
d. Apixaban, Rivaroxaban, Dabigatran
a. Heparin, Enoxaparin
USED TO TREAT ◦ Mechanical Heart valves (prevent stroke/clot formation) a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
c. Warfarin
PT INR a. Heparin, Enoxaparin b. Argatroban, Fondaparinux c. Warfarin d. Apixaban, Rivaroxaban, Dabigatran
c. Warfarin